Pharmaceutical

AstraZeneca champions early kidney disease diagnosis with modelling data

Early diagnosis of chronic kidney disease has both economic and environmental benefits, according to AstraZeneca’s Mina Makar.

Jun 12, 2024 - 04:00
AstraZeneca champions early kidney disease diagnosis with modelling data
Early diagnosis of chronic kidney disease has both economic and environmental benefits, according to AstraZeneca’s Mina Makar.
Read the original article

Tags:

Previous Article

How do supermassive black holes get super massive?

Next Article

Tacalyx extends seed funding round to raise over €14m

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Amgen receives FDA priority review for tarlatamab BLA

Amgen receives FDA priority review for tarlatamab BLA

Dec 14, 2023

BeiGene spin-out Pi Health raises $30m to uptick cancer trial enrolment

BeiGene spin-out Pi Health raises $30m to uptick cancer...

Mar 16, 2024

Charles River and Wheeler Bio partner on therapeutic discovery

Charles River and Wheeler Bio partner on therapeutic di...

Feb 22, 2024